Evidence map›Paper›PMID 34492029›Full record

Observational studyPloS one2021

Megacystis in the first trimester of pregnancy: Prognostic factors and perinatal outcomes.

Emmanuelle Lesieur, Mathilde Barrois, Mathilde Bourdon, Julie Blanc, Laurence Loeuillet, Clémence Delteil, Julia Torrents, Florence Bretelle, Gilles Grangé, Vassilis Tsatsaris and 1 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07165743 (Negative Predictive Value of Rapid Emptying of the Fetal Bladder), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07165743 active not recruitingnot on this mapstarted 2025, after this paper: background citation

Negative Predictive Value of Rapid Emptying of the Fetal Bladder (≤40 Min and Post-void ≤2 mm) on Major Chromosome Aneuploidies at 11-14 Gestational Weeks: A Prospective Diagnostic Accuracy Study

Typeobservational_patient_registrySponsorHaseki Training and Research HospitalRan2025 to 2026Enrolled270ConditionsChromosomal Aneuploidies (e.g., Trisomy 21, Trisomy 18, Trisomy 13), Prenatal Screening AccuracyArms40-Minute Real-Time First-Trimester Ultrasonography
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Emmanuelle LesieurMaternité Port-Royal, AP-HP, Hôpital Cochin, FHU PREMA, Paris, France.ORCID 0000-0002-5501-9441
Mathilde BarroisMaternité Port-Royal, AP-HP, Hôpital Cochin, FHU PREMA, Paris, France.
Mathilde BourdonFaculté de Médecine Paris Centre, Faculté de Santé, Université de Paris, Paris, France.
Julie BlancService de Gynécologie Obstétrique, Hôpital Nord, AP-HM, Chemin des Bourrely, Marseille, France.ORCID 0000-0002-1542-504X
Laurence LoeuilletService d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Clémence DelteilInstitut Médicolégal de Marseille, Hôpital Timone Adultes, Marseille, France.
Julia TorrentsService d'Anatomo-Cytopathologie et Fœtopathologie, Hôpital de la Timone, Marseille, France.
Florence BretelleService de Gynécologie Obstétrique, Hôpital Nord, AP-HM, Chemin des Bourrely, Marseille, France.
Gilles GrangéMaternité Port-Royal, AP-HP, Hôpital Cochin, FHU PREMA, Paris, France.
Vassilis TsatsarisMaternité Port-Royal, AP-HP, Hôpital Cochin, FHU PREMA, Paris, France.
Olivia AnselemMaternité Port-Royal, AP-HP, Hôpital Cochin, FHU PREMA, Paris, France.
Hôpital Cochin · FRAix-Marseille Université · FRCentre National de la Recherche Scientifique · FRHôpital de la Timone · FRHôpital Necker-Enfants Malades · FRInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether bladder size is associated with an unfavorable neonatal outcome, in the case of first-trimester megacystis. MATERIALS AND

methodsThis was a retrospective observational study between 2009 and 2019 in two prenatal diagnosis centers. The inclusion criterion was an enlarged bladder (> 7 mm) diagnosed at the first ultrasound exam between 11 and 13+6 weeks of gestation. The main study endpoint was neonatal outcome based on bladder size. An adverse outcome was defined by the completion of a medical termination of pregnancy, the occurrence of in utero fetal death, or a neonatal death. Neonatal survival was considered as a favorable outcome and was defined by a live birth, with or without normal renal function, and with a normal karyotype.

resultsAmong 75 cases of first-trimester megacystis referred to prenatal diagnosis centers and included, there were 63 (84%) adverse outcomes and 12 (16%) live births. Fetuses with a bladder diameter of less than 12.5 mm may have a favorable outcome, with or without urological problems, with a high sensitivity (83.3%) and specificity (87.3%), area under the ROC curve = 0.93, 95% CI (0.86-0.99), p< 0.001. Fetal autopsy was performed in 52 (82.5%) cases of adverse outcome. In the 12 cases of favorable outcome, pediatric follow-up was normal and non-pathological in 8 (66.7%).

conclusionBladder diameter appears to be a predictive marker for neonatal outcome. Fetuses with smaller megacystis (7-10 mm) have a significantly higher chance of progressing to a favorable outcome. Urethral stenosis and atresia are the main diagnoses made when first-trimester megacystis is observed. Karyotyping is important regardless of bladder diameter.

Indexed as

AdultDuodenumFemaleFetal DiseasesGestational AgeHumansInfant, NewbornKaryotypingPregnancyPregnancy OutcomePregnancy Trimester, FirstPrenatal DiagnosisPrognosisRetrospective StudiesROC CurveSurvival Rate

Identifiers

PMID34492029
PMCPMC8423287
OpenAlexW3198887988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.